XML 16 R4.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Thousands
Jun. 28, 2025
Dec. 28, 2024
Current assets:    
Cash and cash equivalents $ 182,824 $ 194,606
Trade receivables and contract assets, net of allowances for credit losses of $12,838 and $18,301, respectively 767,569 720,915
Inventories 279,550 278,544
Prepaid assets 109,998 103,210
Other current assets 129,921 105,796
Total current assets 1,469,862 1,403,071
Property, plant and equipment, net 1,606,733 1,604,014
Venture capital and strategic equity investments 216,073 218,350
Operating lease right-of-use assets, net 385,756 412,490
Goodwill 2,936,265 2,846,608
Intangible assets, net 602,452 723,400
Deferred tax assets 46,943 42,179
Other assets 296,461 278,233
Total assets 7,560,545 7,528,345
Current liabilities:    
Accounts payable 145,798 140,337
Accrued compensation 227,509 179,418
Deferred revenue 268,340 248,322
Accrued liabilities 231,567 232,010
Other current liabilities 207,224 194,014
Total current liabilities 1,080,438 994,101
Long-term debt, net and finance leases 2,332,374 2,240,205
Operating lease right-of-use liabilities 453,664 483,789
Deferred tax liabilities 109,273 106,960
Other long-term liabilities 185,210 195,212
Total liabilities 4,160,959 4,020,267
Commitments and contingencies (Notes 10, 12, and 14)
Redeemable noncontrolling interests 39,956 41,126
Equity:    
Preferred stock, $0.01 par value; 20,000 shares authorized; no shares issued and outstanding 0 0
Common stock, $0.01 par value; 120,000 shares authorized; 51,344 shares issued and 49,209 shares outstanding as of June 28, 2025, and 51,141 shares issued and outstanding as of December 28, 2024 513 511
Additional paid-in capital 1,992,718 1,966,237
Retained earnings 1,889,895 1,812,100
Treasury stock, at cost, 2,136 and zero shares, as of June 28, 2025 and December 28, 2024, respectively (363,338) 0
Accumulated other comprehensive loss (166,467) (317,345)
Total Charles River Laboratories International, Inc. equity 3,353,321 3,461,503
Nonredeemable noncontrolling interest 6,309 5,449
Total equity 3,359,630 3,466,952
Total liabilities, redeemable noncontrolling interests and equity $ 7,560,545 $ 7,528,345